Skip to content

Olsalazine

Aminosalicylate — ALIMENTARY TRACT AND METABOLISM

Also known as: azodisalicylate, CJ 91B, dipentum, olsalazine sodium

OfpFDA approvedATC A07EC03

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Olsalazine is an ofp drug in the Aminosalicylate class catalogued in DrugCentral. It was first approved by the FDA in 1990. DrugCentral lists 4 molecular targets, including BLVRB, ALOX5 and PPARG. Recorded indications include Ulcerative colitis in remission.

  • Approval status: ofp (first approved 1990 by the FDA).
  • Drug class: Aminosalicylate.
  • Molecular targets: BLVRB, ALOX5, PPARG and PTGS1|PTGS2 (4 listed in DrugCentral).
  • Indications: Ulcerative colitis in remission.
  • ATC code: A07EC03 (Aminosalicylic acid and similar agents).
  • Molecular formula: C14H10N2O6; molecular weight 302.24 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Ulcerative colitis in remission

Off-label uses (2)

  • Crohn's disease
  • Ulcerative colitis

Contraindications (5)

  • Allergic rhinitis
  • Asthma
  • Diarrhea
  • Disease of liver
  • Kidney disease

Mechanism & targets

Established pharmacologic classAminosalicylate

Molecular targets (4)

TargetGeneActionActivity
Flavin reductase (NADPH)BLVRBunknownKd 7.16
Arachidonate 5-lipoxygenaseALOX5inhibitor—
Peroxisome proliferator-activated receptor gammaPPARGagonist—
CyclooxygenasePTGS1|PTGS2inhibitor—

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1990-07-31FDA—MEDA PHARMS

ATC classification

ATC codeTherapeutic hierarchy
A07EC03ALIMENTARY TRACT AND METABOLISM › ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS › INTESTINAL ANTIINFLAMMATORY AGENTS › Aminosalicylic acid and similar agents

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA termLLR
Colitis ulcerative57.7

Chemical structure

Molecular formulaC14H10N2O6
Molecular weight302.24 g/mol
CAS number6054-98-4
InChIKeyQQBDLJCYGRGAKP-UHFFFAOYSA-N
PubChem CID22419
OC(=O)C1=CC(=CC=C1O)N=NC1=CC(C(O)=O)=C(O)C=C1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Olsalazine used for?

DrugCentral lists the following indications for Olsalazine: Ulcerative colitis in remission.

How does Olsalazine work?

Its molecular targets in DrugCentral include BLVRB, ALOX5 (inhibitor), PPARG (agonist) and PTGS1|PTGS2 (inhibitor).

When was Olsalazine first approved?

Olsalazine was first approved by the FDA in 1990.

What drug class does Olsalazine belong to?

Olsalazine is in the Aminosalicylate class.

What is the chemical formula of Olsalazine?

Olsalazine has the molecular formula C14H10N2O6 and a molecular weight of 302.24 g/mol.

Browse: all drugs starting with O · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFP
First approval1990-07-31
AgencyFDA
Targets4
Indications1
FormulaC14H10N2O6
DrugCentral ID1988
Interactive profile